Mini Review Open Access
Volume 4 | Issue 1 | DOI: https://doi.org/10.33696/AIDS.4.027

Known and New Routes to Neutralize HIV-1 with Camelid Single Chain Antibody Fragments

  • 1Retired Unilever, QVQ Holding,b.v. and Utrecht University, The Netherlands
  • 2Department of Applied Stem Cell Technologies, TechMed Centre, University of Twente, Enschede, the Netherlands
  • 3Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt, Germany
  • 4Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden
+ Affiliations - Affiliations

Corresponding Author

C. Theo Verrips, theo.verrips@outlook.com

Received Date: January 12, 2022

Accepted Date: April 20, 2022

Author Information X